Spotlight series
The Spotlight series features evidence-based reports on topics at the forefront of debates about the future of heart failure care.
Find out more
Action Statement on Heart Failure
A call to action outlining clear policy recommendations for European institutions to address the growing burden of heart failure.
Find out more
Heart failure policy and practice in Europe
Heart failure policy and practice in Europe aims to support advocates with clear outline of policy issues and best practice in heart failure across 11 European countries.
Find out more
heart graphic

Helping advance meaningful policy change on heart failure

The Heart Failure Policy Network is an independent, multidisciplinary platform of healthcare professionals, advocacy groups and policymakers from across Europe.

We aim to raise awareness of the unmet needs surrounding heart failure and its care, and to help drive meaningful changes in policy and practice.

Find out more
Latest
HFPN calls for the improved management of worsening heart failure in a new report
21 April 2022

The Heart Failure Policy Network has launched the ‘Spotlight on worsening heart failure’, which highlights the actions that decision-makers can take to prevent heart failure hospitalisations.

Read article
Latest
The future of heart failure care – key lessons learnt from the pandemic
11 March 2022

After two years of disruption, many countries are lifting COVID-19 restrictions. We have been talking with the HFPN community about the key lessons learnt from the pandemic and how they can help shape the future of heart failure care.

Read article
Latest
HFPN Strategic Adviser Ed Harding discusses cardiovascular care with Health Europa Quarterly
19 January 2022

Ed Harding recently spoke with Health Europa Quarterly (HEQ) about the key challenges affecting the diagnosis, screening and treatment of heart failure.

Read article
heart failure graphic
What is heart failure?

Affecting at least 15 million adults in Europe, heart failure is a common but complex clinical syndrome that occurs when the heart is unable to pump enough blood to meet body’s needs.

Its prevalence is expected to rise due to population ageing and improved survival rates for other long-term conditions, including cardiovascular diseases.

Find out more
The Heart Failure Policy Network is made possible with financial support from AstraZeneca, Vifor Pharma, Bayer AG and Boehringer Ingelheim. The content produced by the Network is non-promotional and not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members.